Clinical Trial Update: Prospective L-arginine Study [Phase 1]

View source ↗

Summary

Phase 1 prospective study of L-arginine in heart transplant patients was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant

Drugs mentioned

• L-Arginine (L-Arginine)

Snippet

Sponsor: University of Michigan | Conditions: Heart Transplant | Phase 1 | Status: TERMINATED